By Matt Kelly2005-08-23T00:00:00
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2016-03-15T14:45:00Z By David Bogoslaw
Valeant Pharmaceuticals’ announced financial restatement raises questions about the drug company’s compliance program and its business model. But it might also serve as an early warning to all publicly listed U.S. companies about the increased room for misjudging the booking of sales once FASB rolls out its new revenue recognition ...
2026-03-20T18:15:00Z By Jason Somrak, CW guest columnist
Financial crime is becoming faster, smarter, and more difficult to trace. By 2026, banks and regulators will approach compliance with a new mindset. The shift is away from reaction and toward prevention, partnership, and people.
2026-03-19T14:43:00Z By Tom Fox
A sweeping proposed federal procurement clause would push AI oversight out of policy decks and into compliance operations, vendor management, and real-time control testing.
Site powered by Webvision Cloud